The Scottish Health Survey 2025 - volume 1: main report

This report presents results for the Scottish Health Survey 2025, providing information on the health and factors relating to health of people living in Scotland.


3. Respiratory Conditions

Introduction

Infectious respiratory disorders and long-term respiratory conditions, such as asthma, chronic obstructive pulmonary disease (COPD) and long COVID, are a considerable challenge for the individuals that live with them and for health services in Scotland, particularly in light of an ageing population[i]. Many respiratory conditions are not curable, however, treatment can help to improve symptoms and quality of life[ii].

Asthma is a long-term disease of the small airways in the lungs and is characterized by breathlessness, wheezing, coughing and chest tightness[iii]. Whilst the underlying causes are not fully understood, risk factors include infections/viruses, hormones, environmental, lifestyle (including smoking, diet and obesity), occupational and genetic disposition[iv][iii].

COPD is the name given to a group of lung conditions that cause breathing difficulties that get worse over time[v],[vi]. The ageing population, along with the additional complication of older COPD patients being more likely to have other long-term conditions, presents a further challenge in managing COPD in Scotland[vii]. Smoking is the main cause of COPD with an estimated 9 in 10 of those with the condition in the UK having either smoked or continuing to smoke[viii].

Long COVID refers to symptoms that develop during or after a COVID-19 infection that continue for 4 weeks or more and are not attributed to another condition/diagnosis. The overlapping long COVID symptoms that are sometimes experienced can affect body systems including the respiratory system[ix]. The ongoing impact of long COVID can be debilitating for some with impacts on daily activities and quality of life reported to include fatigue, breathlessness, anxiety, depression and cognitive impairment[x].

Policy background

The Respiratory care – action plan: 2021 to 2026 has supported national work to strengthen prevention, diagnosis, care and support for people living with respiratory conditions. Through the Centre for Sustainable Delivery[xi], national pathways are being developed for severe asthma, COPD, sleep apnoea and interstitial lung disease. Work is also underway to improve access to pulmonary rehabilitation, a key intervention for people with chronic respiratory conditions.

The Scottish Government published the Health and Social Care Service Renewal Framework (SRF) in July 2025. The first Major Change of the SRF includes a specific focus on long-term conditions. As part of this the Scottish Government are continuing to engage with the third sector, clinicians and others to develop the approach to long-term conditions, including respiratory conditions.

The Scottish Government supports NHS boards to develop specialist support for people with long COVID, myalgic encephalomyelitis (ME)/chronic fatigue syndrome (CFS) and other similar conditions.

Comparability with other UK statistics

The latest asthma prevalence estimates for both adults and children in England are available in the Health Survey for England 2018. The survey has a different sampling methodology to the Scottish Health Survey, so asthma prevalence estimates across the surveys are only partially comparable. There are no comparable statistics collected in Wales or Northern Ireland.

Results

In this chapter, the following data is presented:

  • Table 3.1. Doctor-diagnosed asthma, wheezed in last 12 months, and ever wheezed, 2008 to 2025, by sex
  • Table 3.2. Doctor-diagnosed asthma (age-standardised), 2025, by area deprivation and sex
  • Table 3.3. Doctor-diagnosed chronic obstructive pulmonary disease (COPD), 2008 to 2025, by sex
  • Table 3.4. Whether currently has self-reported long COVID, 2021, 2023 to 2025, by sex
  • Table 3.5. Whether current long COVID limits ability to carry out day-to-day activities, 2021, 2023 to 2025, by sex
  • Table 3.6. Whether long COVID symptoms worsen after mental and/or physical effort, 2024 to 2025, by sex

These tables are available as supporting documents.

Doctor-diagnosed asthma and wheezing

In 2025, 17% of adults reported having doctor-diagnosed asthma and this proportion has remained between 15%-18% since 2010. Sixteen per cent had wheezed in the last 12 months, similar to previous years (14%-18% since 2008). Twenty-seven per cent reported ever having wheezed in their lifetime, a proportion that has remained in the range 25%-31% since 2008. There was no significant variation by sex.                  

Figure 3.1: Seventeen per cent of adults reported having doctor-diagnosed asthma, 16% wheezed in the last 12 months and 27% ever wheezed in their lifetime

Prevalence of doctor-diagnosed asthma, wheezing in the last 12 months and ever wheezing, 2008 to 2025

A line graph showing trends in the prevalence of doctor-diagnosed asthma, wheezing in the last 12 months and ever wheezing for adults from 2008 to 2025. The graph shows that 17% of adults reported having doctor-diagnosed asthma, 16% wheezed in the last 12 months and 27% ever wheezed in their lifetime.

Nine per cent of children reported doctor-diagnosed asthma, in line with recent years (8%-10% since 2015). The proportion of children that ever wheezed remained at the same level as in 2024 (21%) and the proportion who wheezed in the last 12 months (12%) was similar to 2024 (13%). There was no significant variation by sex.                                                           

There were no significant differences in the prevalence of doctor-diagnosed asthma by area deprivation.                                                                    

Tables 3.1 - 3.2

Doctor-diagnosed chronic obstructive pulmonary disease (COPD)

In 2025, the prevalence of doctor-diagnosed COPD was 4% and it has remained at similar levels since 2008 (between 3% and 5%). There was no significant variation by sex.

Figure 3.2: Four per cent of adults reported doctor-diagnosed chronic obstructive pulmonary disease

Prevalence of doctor-diagnosed chronic obstructive pulmonary disease, 2008 to 2025

A line graph showing trends in the prevalence of chronic obstructive pulmonary disease for adults from 2008 to 2025. The graph shows that 4% of adults reported doctor-diagnosed chronic obstructive pulmonary disease.

Table 3.3

Self-reported long COVID

In 2025, 5% of adults reported currently having long COVID, the same as in 2021 and lower than the past two years (8% in 2023 and 7% in 2024). There was not a significant difference between males and females.

In 2025, 1% of children reported currently having long COVID, in line with previous years (1%-2% since 2021). There was no significant variation by sex.

Figure 3.3: Five per cent of adults and 1% of children reported currently having long COVID

Prevalence of current self-reported long COVID, 2021 to 2025

A line graph showing trends in the prevalence of long COVID for adults and children from 2021 to 2025. The graph shows that 5% of adults and 1% of children reported currently having long COVID.

In 2025, the proportion of adults who reported that they have long COVID which has reduced their ability to carry out day-to-day activities ‘a lot’ remained the same as in 2024 (2%), whereas the proportion of those who reported that it reduced their ability ‘a little’ dropped from 3% in 2024 to 2% in 2025. Females were more likely than males to report that long COVID reduced their ability ‘a little’ (2% and 1% respectively).

In 2025, 56% of adults who reported having long COVID also reported that their symptoms worsened after mental and/or physical effort, lower than in 2024 (59%), but this difference was not significant. There was no significant variation by sex.

Tables 3.4 - 3.6

References and Notes 

[i]   Scottish Government (2021). Respiratory care – action plan: 2021 to 2026. See: https://www.gov.scot/publications/respiratory-care-action-plan-scotland-2021-2026/pages/4/

[iv]   Asthma and Lung UK. See: What is asthma? | Asthma + Lung UK

[vi]   World Health Organisation (WHO). See: Chronic respiratory diseases

[vii]   Scottish Government (2017). Chronic Obstructive Pulmonary Disease (COPD): best practice guide. See: https://www.gov.scot/publications/copd-best-practice-guide/ 

[x]   Walker S. et al. (2023) Impact of fatigue as the primary determinant of functional limitations among patients with post-COVID-19 syndrome: a cross-sectional study. BMJ Open, 13. See: https://bmjopen.bmj.com/content/bmjopen/13/6/e069217.full.pdf

Contact

ScottishHealthSurvey@gov.scot

Back to top